Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 325

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 325
---
 not directly attributable to either period but instead were contingent on the Merger. The opening
cash balance in the condensed consolidated statement of cash flow of $1.88 million consists of $0.92 million from PBAX and $0.96 million
from Predecessor. The number of shares of Common Stock issued and amounts recorded on the line within stockholders’ deficit are
reflected below to arrive at the opening consolidated balance sheet of the Company.

|                                                                         |     | Convertible     
 Preferred Stock 
 Series          
 A               
 Shares          |        |     | Amount |           |     | Series 
 A      
 Common 
 Stock  
 Shares |         |   |     | Amount |    |   |     | Additional 
 Paid-in    
 Capital    |            |   |     | Stock        
 Subscription 
 Receivable   |            |   |     | Accumulated 
 Deficit     |             |   |     | Total |             |   |
|:------------------------------------------------------------------------|:----|:----------------|-------:|:----|:-------|----------:|:----|:-------|--------:|:--|:----|:-------|---:|:--|:----|:-----------|-----------:|:--|:----|:-------------|:-----------|:--|:----|:------------|:------------|:--|:----|:------|------------:|:--|
| PBAX                                                                    
 Closing Equity as of February 13, 2024                                  |     |                 |      - |     | $      |         - |     |        |  54,812 |   |     | $      |  6 |   |     | $          |        541 |   |     | $            | -          |   |     | $           | (12,709,426 | ) |     | $     | (12,708,879 | ) |
| Forfeiture                                                              
 of founders shares                                                      |     |                 |      - |     |        |         - |     |        |  (8,750 | ) |     |        | (1 | ) |     |            |          1 |   |     |              | -          |   |     |             | -           |   |     |       |           - |   |
| Adjusted                                                                
 shares outstanding                                                      |     |                 |      - |     |        |         - |     |        |  46,062 |   |     |